Zelira Therapeutics Limited (ASX:ZLD)

Zelira Therapeutics Revenue

In the fiscal year ending June 30, 2025, Zelira Therapeutics had annual revenue of 656.00 AUD, down -99.31%. Zelira Therapeutics had revenue of 1.00 in the half year ending June 30, 2025, a decrease of -100.00%. That makes Zelira Therapeutics the 47,725th largest company in the world by revenue and 1,557th in Australia.

• Revenue: 656.00
• Revenue Growth: -99.31%
• P/S Ratio: 9,067.95
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.95M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• United States of America 516.00 78.7%
• Australia 140.00 21.3%

Fiscal year ended Jun 30, 2025 See the full Zelira Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	656.00	-94.30K	-99.31%
Jun 30, 2024	94.95K	-206.17K	-68.47%
Jun 30, 2023	301.12K	-1.24M	-80.45%
Jun 30, 2022	1.54M	877.31K	132.26%
Jun 30, 2021	663.32K	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 26, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error